Patents Assigned to Vanderbilt University
  • Patent number: 5551525
    Abstract: A climber robot has front and rear legs joined together by a pivoting knee joint and having pivoting ankle joints at their distal ends. Pneumatic muscle pairs attached to each leg allow the robot to move vertically and horizontally and make easy transitions over obstacles and from the horizontal to vertical plane.
    Type: Grant
    Filed: August 19, 1994
    Date of Patent: September 3, 1996
    Assignee: Vanderbilt University
    Inventors: Robert T. Pack, Moenes Z. Iskarous, Kazuhiko Kawamura
  • Patent number: 5527678
    Abstract: A cagB gene of H. pylori is provided. This nucleic acid can be the nucleic acid consisting of nucleotides 193 through 1158 in the sequence set forth as SEQ ID NO:1, which is an example of a native coding sequence for CagB. This nucleic acid can also be in a vector suitable for expressing a polypeptide encoded by the nucleic acid. A cagC gene of H. pylori is provided. This nucleic acid can be the isolated nucleic acid consisting of nucleotides 1170 through 3830 in the sequence set forth as SEQ ID NO:3, which is an example of a native coding sequence for CagC. This nucleic acid can also be in a vector suitable for expressing a polypeptide encoded by the nucleic acid. Isolated nucleic acids that specifically hybridize with cagB and cagC are provided. CagB and CagC are associated with peptic ulceration and other clinical syndromes in humans infected with strains of H. pylori that express it.
    Type: Grant
    Filed: October 21, 1994
    Date of Patent: June 18, 1996
    Assignee: Vanderbilt University
    Inventors: Martin J. Blaser, Murali K. R. Tummuru, Smita A. Sharma
  • Patent number: 5512580
    Abstract: This invention provides a method of and compositions for increasing or maintaining glomerular filtration rate while preserving renal structure in a patient comprising administering an angiotensin II type 1 vascular receptor antagonist to the patient, independent of its effects on systemic blood pressure. The invention provides that, by administering the AII type 1 receptor antagonist, blood flow to the kidney can be improved without sacrificing intraglomerular pressure and therefore glomerular filtration and that even with this enhanced glomerular pressure and filtration, renal structure is preserved.
    Type: Grant
    Filed: July 25, 1994
    Date of Patent: April 30, 1996
    Assignee: Vanderbilt University
    Inventors: Valentina Kon, Agnes Fogo, Iekuni Ichikawa
  • Patent number: 5502773
    Abstract: A method and apparatus for the processing of DNA sequence image data in real time is implemented using a series of linked neural network processors. As raw image data is received from a sequencing machine, it is buffered and then separately transformed in real time in the processors to enhance the signals indicative of the unknown DNA sequence. A fourth processor receives the transformed data and determines and reports the sequence indicating events.
    Type: Grant
    Filed: July 6, 1993
    Date of Patent: March 26, 1996
    Assignee: Vanderbilt University
    Inventors: Clark Tibbetts, James B. Golden, III, Deborah L. Torgersen
  • Patent number: 5480631
    Abstract: Novel, substituted benzamides in radioiodinated form are useful in radiopharmaceutical compositions in nuclear medicine as imaging agents to detect, visualize, and analyze the distribution and function of the dopamine D2 receptor in the mammalian brain. These compounds have a specific combination of lipophilicity and dopamine D2 receptor affinity required to attain a required image contrast. The iodinated benzamides identified by the above discovery can be made by reacting a trialkyltin substituted benzamide with an acid in the presence of radioactive iodine which, in turn, is generated by in situ oxidation of an appropriate iodide nuclide salt.
    Type: Grant
    Filed: May 28, 1992
    Date of Patent: January 2, 1996
    Assignee: Vanderbilt University
    Inventors: Tomas De Paulis, Robert M. Kessler, Howard E. Smith, Aaron Janowski, Jeffrey A. Clanton
  • Patent number: 5475021
    Abstract: The present invention includes N-substituted maleimides (1(H)-Pyrrole-2,5-dione (Maleimide) analogs and succinimides which act as potent nonsteroidal anti-inflammatory drugs and are capable of dual inactivation or selective inactivation of the cyclooxygenase and the peroxidase activities of prostaglandin endoperoxide synthase (PGHS).
    Type: Grant
    Filed: December 3, 1993
    Date of Patent: December 12, 1995
    Assignee: Vanderbilt University
    Inventors: Lawrence J. Marnett, Amit S. Kalgutkar
  • Patent number: 5462866
    Abstract: Microspheres of a substantially uniform diameter are produced having a central portion composed of a solution of a polyanion containing a biological material, and an outer permeable membrane enclosing the central portion which is a complex of the polyanion and a polycation. The biological material has a molecular size greater than 150,000 Daltons, and the membrane has a porosity such that the biological material does not permeate the membrane. The biological material may comprise living cells or living tissue. The microspheres are formed by individually enveloping falling droplets of a polyanion solution with a collapsing annular sheet of a polycation solution while the sheet is traveling downwardly at the same velocity as the droplets.
    Type: Grant
    Filed: September 23, 1993
    Date of Patent: October 31, 1995
    Assignee: Vanderbilt University
    Inventor: Taylor G. Wang
  • Patent number: 5453357
    Abstract: The present invention provides a non-mouse pluripotential embryonic stem cell which can:(a) be maintained on feeder layers for at least 20 passages; and(b) give rise to embryoid bodies and multiple differentiated cell phenotypes in monolayer culture. The invention further provides a method of making a pluripotential embryonic stem cell comprising administering a growth enhancing amount of basic fibroblast growth factor, leukemia inhibitory factor, membrane associated steel factor, and soluble steel factor to primordial germ cells under cell growth conditions, thereby making a pluripotential embryonic stem cell.
    Type: Grant
    Filed: October 8, 1992
    Date of Patent: September 26, 1995
    Assignee: Vanderbilt University
    Inventor: Brigid L. M. Hogan
  • Patent number: 5434253
    Abstract: An isolated nucleic acid encoding the Helicobacter pylori recombinase comprising the nucleotide sequence defined in the Sequence Listing as SEQ ID NO:1 is provided. Also provided is an isolated nucleic acid that selectively hybridizes with the nucleic acid of claim 1 under stringent conditions and has at least 70% complementarity with the segment of the nucleic acid of SEQ ID NO:1 to which it hybridizes. Also provided is a mutant strain of H. pylori that does not express a functional recombinase (recA.sup.- mutant). An immunogenic amount of the recA.sup.- mutant H. pylori in a pharmaceutically acceptable carrier is provided. A method of immunizing a subject against infection by H. pylori comprises administering to the subject an immunogenic amount of mutant H. pylori in a carrier for the mutant.
    Type: Grant
    Filed: March 21, 1994
    Date of Patent: July 18, 1995
    Assignee: Vanderbilt University
    Inventors: Stuart A. Thompson, Martin J. Blaser
  • Patent number: 5420977
    Abstract: In a fault diagnostic system, an operator interface simultaneously displays an operations hierarchy and a components hierarchy in two separate windows. The display system is used with a model-based diagnostic system that monitors operational parameters of an industrial process. The diagnostic system identifies possible failure source components in the industrial process and the display system uses these diagnostics to display the most interesting portions of the operations hierarchy and the components hierarchy. The most interesting node, to be displayed with its subtree, is defined as the node at the lowest level of the hierarchy that is both a fault source and that has more children than than other fault sources at that level.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: May 30, 1995
    Assignees: Vanderbilt University, Osaka Gas Co., Ltd.
    Inventors: Janos Sztipanovits, Csaba Biegl, Gabor Karsai, Samir Padalkar, Nobuji Miyasaka, Koji Okuda
  • Patent number: 5408178
    Abstract: The surface or internal structure of diamagnetic and paramagnetic materials is imaged by measuring, preferably with a superconducting quantum interference device (SQUID) magnetometer, perturbations to an applied magnetic field resulting from variations in magnetic susceptibility at an array of locations across the object. The array of perturbation measurements is processed to generate a map of local susceptiblities. For implementation of susceptibility tomography, multiple arrays of perturbation signals for a plurality of relative orientations between the object, the field, and the measurement locations are processed to generate values for local susceptibility at selected sites within the object, such as along a selected sectional plane.
    Type: Grant
    Filed: May 17, 1991
    Date of Patent: April 18, 1995
    Assignees: Vanderbilt University, E.I. Du Pont de Nemours and Company
    Inventors: John P. Wikswo, Jr., Alan Lauder
  • Patent number: 5403112
    Abstract: A crash impact attenuator including one or more cylinders, each bolted or otherwise connected to the adjacent cylinder and such cylinders being connected to the platform of a service vehicle or to an abutment adjacent a highway wherein the cylinders are constructed from a high molecular weight/high density polyethylene material.
    Type: Grant
    Filed: September 8, 1993
    Date of Patent: April 4, 1995
    Assignee: Vanderbilt University
    Inventor: John F. Carney, III
  • Patent number: 5403306
    Abstract: A laser surgery method is disclosed for use in efficient ablation of tissue with little or no thermal damage to adjacent tissues. The wavelength of the surgical laser is tuned to an absorption peak of a proteinaceous material or functional groups contained therein, the amides for example. A suitable power level is chosen to either vaporize or liquify the targeted tissue.
    Type: Grant
    Filed: June 22, 1993
    Date of Patent: April 4, 1995
    Assignee: Vanderbilt University
    Inventors: Glenn S. Edwards, Regan A. Logan, Denis M. O'Day, Michael Copeland
  • Patent number: 5403924
    Abstract: The present invention provides an isolated nucleic acid encoding an approximately 120-128 kilodalton antigen of Helicobacter pylori, or an antigenic fragment thereof, wherein the antigen is associated with peptic ulceration. The present invention also provides methods of detecting the presence of a Helicobacter pylori strain possessing the 120-128 kilodalton antigen in a subject, comprising the steps of contacting an antibody-containing sample from the subject with a detectable amount of the tagA antigen or antigenic fragment of the present invention and detecting the reaction of the antigen or fragment and the antibody. A mutant H. pylori not expressing a functional tagA antigen is also provided.
    Type: Grant
    Filed: April 26, 1993
    Date of Patent: April 4, 1995
    Assignee: Vanderbilt University
    Inventors: Timothy L. Cover, Murali K. R. Tummuru, Martin J. Blaser
  • Patent number: 5371189
    Abstract: The present invention relates to a purified monocyte-derived insulin receptor regulatory factor, which has the biological activity of reducing insulin receptor binding on T-lymphocytes. Additionally, the invention relates to a nucleic acid that codes for the monocyte-derived insulin receptor regulatory factor, a recombinant protein produced therefrom, and an antibody to the factor. The present invention also relates to a method of reducing insulin receptor binding on activated T-lymphocytes, including administration of the protein to a subject.
    Type: Grant
    Filed: April 30, 1993
    Date of Patent: December 6, 1994
    Assignee: Vanderbilt University
    Inventor: J. Harold Helderman
  • Patent number: 5365455
    Abstract: A method and system for automated nucleic acid sequence determination of a polynucleotide, wherein a nucleic acid sequencing ladder comprises signals corresponding to oligonucleotides formed from the polynucleotide, comprising the step of correlating, particularly in a trained neural network or a scatter plot, an intensity variable for each signal in the nucleic acid sequencing ladder with an informative variable for that signal, wherein the informative variable comprises information from at least two adjacent signals in the nucleic acid sequencing ladder, such that each signal in the nucleic acid sequencing ladder identified so as to determine the nucleic acid sequence corresponding to the polynucleotide.
    Type: Grant
    Filed: September 20, 1991
    Date of Patent: November 15, 1994
    Assignee: Vanderbilt University
    Inventors: Clark Tibbetts, John M. Bowling
  • Patent number: 5349185
    Abstract: A microchannel plate detector device is intended for use in the detection of low energy electrons and negative ions in particle time-of-flight measurement systems. A vacuum isolator isolates the microchannel plate signal output from ground as well as from the vacuum chamber of the meaurement system. A coupling unit includes a pulse isolator for separating pulse signals from the microchannel plate DC bias voltage. Electronic circuitry matches the output impedance of the coupling unit to the input impedance of the measurement system signal processor, thereby minimizing reflection and distortion of high frequency pulse signals.
    Type: Grant
    Filed: June 25, 1993
    Date of Patent: September 20, 1994
    Assignee: Vanderbilt University
    Inventor: Marcus H. Mendenhall
  • Patent number: 5348979
    Abstract: Nitrogen retention in human subjects is promoted by administering .beta.-hydroxy-.beta.-methylbutyric acid (HMB). The amount of HMB administered is effective to conserve protein as determined by reduction in urinary nitrogen. The method can be used with patients having a negative nitrogen balance due to disease conditions, and also with normal elderly persons who are subject to protein loss. The HMB may be administered orally or by intravenous infusion.
    Type: Grant
    Filed: December 23, 1992
    Date of Patent: September 20, 1994
    Assignees: Iowa State University Research Foundation Inc., Vanderbilt University
    Inventors: Steven L. Nissen, Paul J. Flakoll, Naji N. Abumrad
  • Patent number: 5315254
    Abstract: A method and apparatus for the accurate non-contact detection and measurement of static electric charge on an object using a reciprocating sensing probe that moves relative to the object. A monitor measures the signal generated as a result of this cyclical movement so as to detect the electrostatic charge on the object.
    Type: Grant
    Filed: July 11, 1991
    Date of Patent: May 24, 1994
    Assignee: Vanderbilt University
    Inventors: Taylor G. Wang, Kuan-Chan Lin, James C. Hightower
  • Patent number: 5308762
    Abstract: A T4 endonuclease V DNA repair enzyme contains an amino acid sequence within its carboxyl terminal region which is involved in dimer specific binding. The region includes polar nonaromatic basic amino acids and aromatic amino acids between amino acid 128 to 137 positions. The specific activity of the enzyme is greatly increased at low salt concentrations when substitutions are made in aromatic amino acids in the carboxy terminal region.
    Type: Grant
    Filed: January 27, 1992
    Date of Patent: May 3, 1994
    Assignee: Vanderbilt University
    Inventor: R. Stephen Lloyd